Rhythm Pharmaceuticals Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 02/17/2026 | 6.67 M | $713.62 M | 17.35% | 10.36% |
| BLACKROCK, INC. | 02/12/2026 | 6.30 M | $674.07 M | -0.08% | 9.79% |
| VANGUARD GROUP INC | 01/29/2026 | 6.21 M | $664.82 M | 24.31% | 9.65% |
| BAKER BROS. ADVISORS LP | 02/17/2026 | 5.60 M | $599.90 M | 0.00% | 8.71% |
| PRIMECAP MANAGEMENT CO/CA/ | 02/11/2026 | 3.48 M | $372.36 M | -18.40% | 5.41% |
| NEA MANAGEMENT COMPANY, LLC | 02/17/2026 | 2.91 M | $311.48 M | 0.00% | 4.52% |
| PERCEPTIVE ADVISORS LLC | 02/17/2026 | 2.55 M | $272.57 M | -10.83% | 3.96% |
| STATE STREET CORP | 02/13/2026 | 2.20 M | $235.34 M | 8.38% | 3.42% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 1.83 M | $195.98 M | -3.32% | 2.85% |
| FMR LLC | 02/17/2026 | 1.71 M | $182.64 M | -20.46% | 2.65% |
| FEDERATED HERMES, INC. | 02/12/2026 | 1.62 M | $173.82 M | -6.02% | 2.52% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 1.56 M | $167.07 M | 11.50% | 2.43% |
| JPMORGAN CHASE & CO | 02/11/2026 | 1.42 M | $152.42 M | 19.86% | 2.21% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 1.38 M | $147.28 M | 0.95% | 2.14% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 02/17/2026 | 1.29 M | $137.57 M | -7.12% | 2.00% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 02/11/2026 | 1.27 M | $135.64 M | 18.54% | 1.97% |
| POLAR CAPITAL HOLDINGS PLC | 02/17/2026 | 1.19 M | $126.88 M | -4.78% | 1.84% |
| JANUS HENDERSON GROUP PLC | 02/17/2026 | 1.13 M | $120.59 M | -2.99% | 1.75% |
| CHECKPOINT CAPITAL L.P. | 02/17/2026 | 992.20 K | $106.21 M | 29.92% | 1.54% |
| CAPITAL RESEARCH GLOBAL INVESTORS | 02/11/2026 | 985.09 K | $105.44 M | 64.66% | 1.53% |
| ALLIANCEBERNSTEIN L.P. | 02/17/2026 | 930.23 K | $99.57 M | -5.05% | 1.45% |
| JENNISON ASSOCIATES LLC | 01/30/2026 | 918.57 K | $98.32 M | 123.20% | 1.43% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 695.74 K | $74.47 M | 22.54% | 1.08% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/17/2026 | 695.01 K | $74.39 M | -3.08% | 1.08% |
| WOODLINE PARTNERS LP | 02/17/2026 | 688.78 K | $73.73 M | 18.72% | 1.07% |
| MORGAN STANLEY | 02/13/2026 | 651.40 K | $69.73 M | 40.03% | 1.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/17/2026 | 621.59 K | $66.53 M | 14.26% | 0.97% |
| LORD, ABBETT & CO. LLC | 02/13/2026 | 619.54 K | $66.32 M | 7.56% | 0.96% |
| PICTET ASSET MANAGEMENT HOLDING SA | 01/29/2026 | 614.66 K | $66.19 M | -10.01% | 0.96% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/13/2026 | 549.02 K | $58.77 M | 25.50% | 0.85% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 532.45 K | $56.99 M | 0.86% | 0.83% |
| CLEARBRIDGE INVESTMENTS, LLC | 02/11/2026 | 506.11 K | $54.17 M | 4.41% | 0.79% |
| LOOMIS SAYLES & CO L P | 02/12/2026 | 503.90 K | $53.94 M | -4.46% | 0.78% |
| SIREN, L.L.C. | 02/13/2026 | 499.98 K | $53.52 M | 0.00% | 0.78% |
| NORTHERN TRUST CORP | 02/17/2026 | 488.22 K | $52.26 M | -4.44% | 0.76% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 02/17/2026 | 475.00 K | $50.84 M | 115.91% | 0.74% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 429.42 K | $45.97 M | 100.00% | 0.67% |
| UBS GROUP AG | 01/29/2026 | 427.24 K | $45.73 M | 1.64% | 0.66% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 341.19 K | $36.52 M | -37.58% | 0.53% |
| OPALEYE MANAGEMENT INC. | 04/13/2026 | 330.00 K | $35.32 M | -28.53% | 0.51% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 310.92 K | $33.28 M | 30.19% | 0.48% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 301.08 K | $32.23 M | 65.10% | 0.47% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 02/17/2026 | 295.84 K | $31.67 M | 63.92% | 0.46% |
| INVESCO LTD. | 02/19/2026 | 291.15 K | $31.16 M | 102.81% | 0.45% |
| CANDRIAM S.C.A. | 04/30/2026 | 287.91 K | $30.82 M | 29.77% | 0.45% |
| SOFINNOVA INVESTMENTS, INC. | 02/13/2026 | 271.39 K | $29.05 M | 9.89% | 0.42% |
| SIO CAPITAL MANAGEMENT, LLC | 02/17/2026 | 265.70 K | $28.44 M | 100.00% | 0.41% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 02/17/2026 | 263.59 K | $28.21 M | 11.29% | 0.41% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 261.16 K | $27.95 M | 89.29% | 0.41% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 250.16 K | $26.78 M | 922.00% | 0.39% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Rhythm Pharmaceuticals Inc. institutional Ownership - FAQ's
During the previous two years, 353 institutional investors and hedge funds held shares of Rhythm Pharmaceuticals Inc.. The most heavily invested institutionals were:
Pictet Asset Management Holding SA: 667,046
Candriam S.C.A.: 464,340
Bank of New York Mellon Corp: 293,298
UBS Group AG: 231,650
Nuveen, LLC: 117,376
abrdn plc: 79,357
113.28% of Rhythm Pharmaceuticals Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 80.47 M shares in the last 24 months. This purchase volume represents approximately $7.48 B in transactions.